Literature DB >> 28567623

Molecular and functional characterization of myxobacteria isolated from soil in India.

Shiv Kumar1, Arun Kumar Yadav1, Priyanka Chambel1, Ramandeep Kaur2,3.   

Abstract

This study reports the isolation of myxobacteria from soil collected from plains in north India. Based on the morphology and 16S rDNA sequence, the isolated myxobacteria were identified as Corallococcus sp., Pyxidicoccus sp., Myxococcus sp., Cystobacter sp. and Archangium sp. The myxobacteria were functionally characterized to assess their ability to produce antibacterial and anticancer metabolites. The isolates were found to be functionally versatile as they produced extracellular bioactive molecules that exhibited high frequency of activities against Bacillus cereus, Mycobacterium smegmatis, Enterobacter cloacae and Pseudomonas syringae. The strains also showed cytotoxic activity against the human cancer cell lines of liver, pancreas, prostrate, bone and cervix. These results indicate the importance of isolating diverse strains of myxobacteria from unexplored habitats to find novel bioactive compounds. Moreover, the bioactive molecules explored in this study are predominantly hydrophilic compounds, obviating the limitations of solubility-related aspect of drug discovery.

Entities:  

Keywords:  Antibacterial; Anticancer; Functional characterization; Myxobacteria

Year:  2017        PMID: 28567623      PMCID: PMC5451356          DOI: 10.1007/s13205-017-0722-9

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  42 in total

1.  Archazolid A-15-O-β-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra.

Authors:  Nicole Horstmann; Sebastian Essig; Svenja Bockelmann; Helmut Wieczorek; Markus Huss; Florenz Sasse; Dirk Menche
Journal:  J Nat Prod       Date:  2011-04-22       Impact factor: 4.050

Review 2.  Bioactive microbial metabolites.

Authors:  János Bérdy
Journal:  J Antibiot (Tokyo)       Date:  2005-01       Impact factor: 2.649

3.  Pedein A and B: production, isolation, structure elucidation and biological properties of new antifungal cyclopeptides from Chondromyces pediculatus (Myxobacteria).

Authors:  Brigitte Kunze; Bettina Böhlendorf; Hans Reichenbach; Gerhard Höfle
Journal:  J Antibiot (Tokyo)       Date:  2008-01       Impact factor: 2.649

Review 4.  Myxobacteria--'microbial factories' for the production of bioactive secondary metabolites.

Authors:  Silke C Wenzel; Rolf Müller
Journal:  Mol Biosyst       Date:  2009-04-23

5.  Myxochelins target human 5-lipoxygenase.

Authors:  Sebastian Schieferdecker; Stefanie König; Andreas Koeberle; Hans-Martin Dahse; Oliver Werz; Markus Nett
Journal:  J Nat Prod       Date:  2015-02-16       Impact factor: 4.050

Review 6.  Antibiotics from myxobacteria.

Authors:  Till F Schäberle; Friederike Lohr; Alexander Schmitz; Gabriele M König
Journal:  Nat Prod Rep       Date:  2014-05-19       Impact factor: 13.423

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

8.  Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties.

Authors:  B Kunze; R Jansen; G Höfle; H Reichenbach
Journal:  J Antibiot (Tokyo)       Date:  1994-08       Impact factor: 2.649

9.  Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity.

Authors:  Daniel Krug; Gabriela Zurek; Ole Revermann; Michiel Vos; Gregory J Velicer; Rolf Müller
Journal:  Appl Environ Microbiol       Date:  2008-03-31       Impact factor: 4.792

10.  Extraordinary expansion of a Sorangium cellulosum genome from an alkaline milieu.

Authors:  Kui Han; Zhi-feng Li; Ran Peng; Li-ping Zhu; Tao Zhou; Lu-guang Wang; Shu-guang Li; Xiao-bo Zhang; Wei Hu; Zhi-hong Wu; Nan Qin; Yue-zhong Li
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.